|Day Low/High||61.65 / 62.31|
|52 Wk Low/High||45.76 / 68.34|
The most important market takeaway right now is that both the Nasdaq Composite and S&P 500 have filled their respective gaps and retaken their 50-day simple moving averages.
These are the top five misconceptions about presidential elections -- and the stocks that you should look at right now.
The market is reflecting a triumph of big business over small business, and here's what that means for individual stocks.
Aggressive traders could go long BMY at two price levels.
Even more important than fiscal support moving forward would be the concept of Covid-19 very soon being effectively treatable for the public.
It's remarkable to see such excitement based on totally contradictory theories and themes.
BMY's announced acquisition of MyoKardia for $13B comes less than a year after its purchase of Celgene.
This diversification strategy lets you to capture stock market upside, while not risking your shirt.
6 favorite stocks and ETFs in the biotech and pharmaceutical sector, including a diversified basket of Covid-19 vaccine names.
The market's performance in the three months leading up to a presidential election has displayed an uncanny ability to forecast which party will win the White House.
BMY sees reason for optimism over the final half of the year.
Check out the Dow Transports and the Dow Industrials.
These pharmaceutical favorites continue to make progress on a number of fronts including a Covid-19 vaccine.
Many quality companies that fit into the socially responsible investing camp offer direct-purchase plans, allowing investors an easy way to build an SRI portfolio.
I like putting some of my money with incredibly successful folks who are well-connected and have a history of success.
The bullish reversal pattern is appearing not just in single names, but also in whole sectors.
As Treasury heads for longer-dated issuance and names like PTON run higher on earnings, selloffs late in the trading day continue.
The small biotech's market cap sits at $125 million, the low end of what I believe is fair.
They buy and buy and buy. The same stocks. Over and over. No end to it.
Now that the service economy is pretty much stopped in its tracks, here are promising areas, including technology as manufacturing, to consider.
At the end of the day, investors really have only three choices to make when managing an investment portfolio -- buy, hold, or sell.
For reliable income, a portfolio strategy generating monthly payouts, an opportunity in dividend kings, and favorites among taxable bond funds.
Merger activity is the number 1 driver I am watching for biotech growth.
This move by Beijing comes on top of massive injections of liquidity into that nation's financial system earlier this week.
AbbVie's weekly chart indicates its stock has room to run long term, but its daily chart suggests a rally in its shares is not imminent.
These companies all could be strong -- even if the 2019 nCoV fear spreads.